Back to search
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The AIM HIGHer Clinical Trial will evaluate the safety and efficacy of Cardiac Contractility Modulation (CCM) therapy in patients with heart failure with LVEF ≥…
This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF.
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovas…
This will be a two-arm investigator-initiated randomized controlled study of patients with nHCM and LV ejection fraction ≥50% and NYHA II-III symptoms, normal i…
To ascertain the potential symptom improvement assessed by Cardiopulmonary Exercise Testing (CPET) in subjects with heart failure with preserved ejection fracti…